Quality Control of Tablets Lecture 1
Quality Control of Tablets Lecture 1
Quality Control of Tablets Lecture 1
:Definition
The tablet should include the correct dose of the drug (Weight. 1
.uniformity and content uniformity test)
The appearance of the tablet should be elegant and its weight, size and . 4
appearance should be consistent (Visual observation, weight variation,
.thickness and diameter of the tablet)
.The tablet should be packed in a safe manner. 5
Official Quality control tests for tablets (Compendial tests)
British Pharmacopoeia (B.P.) & US Pharmacopoeia (USP)
Non-Compandial tests
There are many tests that frequently applied to tablets for which
there are non-pharmacopoeial requirements but will form a part
.of manufacture's owner product specifications
.Tablet thickness- 1
.Tablet hardness- 2
I. Official standards (Q. C. tests) for tablets
(Compendial tests)
:Uniformity of active ingredient
.To ensure a constant dose of drug between individual tablets
Traditionally, dose variation between tablets is tested in two separate
;tests
Weight uniformity- 1
Content uniformity- 2
If the drug forms greater part of the tablet ( more than 25 mg and
25%), any variation in the tablet weight obviously indicates a variation
in the active ingredient. (Weight uniformity test)
If the drug is potent (USP specifies less than < 25 mg of the active
ingredient, or comprising <25%byweightofunit), the excipients
form the greater part of the tablet weight and the correlation between
the tablet weight and amount of the active ingredient can be poor, in this
.case another test (Content uniformity) must be performed
Weight uniformity (weight variation). 1
- Weigh 20 tablets individually (i.e. determine the weight of each
tablet alone; X1, X2, X3 X20)
- Calculate the average weight of tablets ( = Total weight of tablets )
Number of tablets
Average weight of tablets (X) = (X1+X2 +X3++ X20)/20
Pharmaceutical form Average tablet Percentage deviation
weight (X)
Tablets mg or less 80 10
mg 250 - > 80< 7.5
mg or more 250 5
Weight variation testing
Causes of weight variation
The size & distribution of the granules being compressed (presence of. 1
too large or too fine granules).
2. Poor flow and high speed turret speed (incomplete filling of die),.
3. Poor mixing. (Sometimes the lubricants & glidants have not been
well distributed).
4. When lower punches are of unequal lengths, the fill of each die varies
because the fill is volumetric
USP defines content uniformity test for tablets containing less than < 25
mg or less than < 25% drug substance in case of coated or uncoated
.tablets
BP procedure
.Determining the amount of drug in a sample of tablets (10 )
.The average drug content is calculated
The content of the individual tablets should fall within specified limits
in terms of % deviation from the LC (85 115%). If not comply, repeat
.using 20 more tablets. No one should be 75 125% deviation
All tablets must pass a test for disintegration except Chewable tablets
.and some Extended release tablets
Six tubes opened at the upper end and closed by a screen at the lower
The end point of the test (i.e. complete disintegration) is achieved when
no tablet fragments remain on the screen (fragments of coating may
remain).
The preparation complies with the test if the time to reach this
end-point is below given limit; < 30 minutes for uncoated immediate
release tablets. but varying from 2 min for nitroglycerin sublingual
tablets to up to 4 hrs for buccal tablets.
Enteric coated tablets are similarly tested except that the tablets are
tested first in the simulated gastric fluid (0.1N HCl) for specific time
(2hr in B.P. and 1 hr in USP) for a positive test, after which no signs of
disintegration, cracking or softening must be seen, followed by
immersion in stimulated intestinal fluid (Phosphate buffer pH 6.8) for
the time stated in the individual monograph, during which time the
.tablets disintegrate completely